These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12127917)

  • 21. Prophylaxis of catheter-related thrombosis in cancer patients.
    Prandoni P
    Lancet; 2009 Feb; 373(9663):523-4. PubMed ID: 19217973
    [No Abstract]   [Full Text] [Related]  

  • 22. Cost effectiveness of extended treatment with low molecular weight heparin (dalteparin) in unstable coronary artery disease: results from the FRISC II trial.
    Janzon M; Levin LA; Swahn E;
    Heart; 2003 Mar; 89(3):287-92. PubMed ID: 12591833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The "superiority" of enoxaparin for treatment of acute coronary syndromes.
    Noviasky JA; Gaffney BJ
    Pharmacotherapy; 2001 Oct; 21(10):1250-2. PubMed ID: 11601672
    [No Abstract]   [Full Text] [Related]  

  • 24. [Low-molecular weight heparin and acute coronary syndrome: theoretical background and its use in clinical practice].
    Ottani F; Ferrini D; Di Pasquale G; Galvani M
    Ital Heart J Suppl; 2001 Sep; 2(9):958-71. PubMed ID: 11675833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials.
    Areia AL; Fonseca E; Areia M; Moura P
    Arch Gynecol Obstet; 2016 Jan; 293(1):81-86. PubMed ID: 26059084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-molecular-weight heparins during pregnancy.
    Many A; Koren G
    Can Fam Physician; 2005 Feb; 51(2):199-201. PubMed ID: 15751560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perioperative management of warfarin therapy: to bridge or not to bridge, that is the question.
    Douketis JD
    Mayo Clin Proc; 2008 Jun; 83(6):628-9. PubMed ID: 18533078
    [No Abstract]   [Full Text] [Related]  

  • 29. Rationale for low-molecular weight heparin in coronary stenting.
    Zidar JP
    Am Heart J; 1997 Nov; 134(5 Pt 2):S81-7. PubMed ID: 9396639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery: a meta-analysis of randomised clinical trials.
    Palmer AJ; Koppenhagen K; Kirchhof B; Weber U; Bergemann R
    Haemostasis; 1997; 27(2):75-84. PubMed ID: 9212355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism.
    Lee AY; Rickles FR; Julian JA; Gent M; Baker RI; Bowden C; Kakkar AK; Prins M; Levine MN
    J Clin Oncol; 2005 Apr; 23(10):2123-9. PubMed ID: 15699480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-molecular weight heparins.
    Talley JD
    J Ark Med Soc; 1997 Apr; 93(11):555-6. PubMed ID: 9114648
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of anticoagulants on cancer risk and survival: systematic review.
    Tagalakis V; Blostein M; Robinson-Cohen C; Kahn SR
    Cancer Treat Rev; 2007 Jun; 33(4):358-68. PubMed ID: 17408861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dalteparin: new indication. Prophylaxis in medical patients: no advance.
    Prescrire Int; 2005 Feb; 14(75):14-5. PubMed ID: 15751168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weight watching in cardiology: low molecular weight heparin for acute coronary syndromes.
    Levi M; Peters RJ; Büller HR
    Cardiovasc Res; 1998 Mar; 37(3):564-6. PubMed ID: 9659439
    [No Abstract]   [Full Text] [Related]  

  • 36. Low-Molecular-Weight Heparin and the Relative Risk of Surgical Site Bleeding Complications: Results of a Systematic Review and Meta-Analysis of Randomized Controlled Trials of Venous Thromboprophylaxis in Patients After Total Joint Arthroplasty.
    Suen K; Westh RN; Churilov L; Hardidge AJ
    J Arthroplasty; 2017 Sep; 32(9):2911-2919.e6. PubMed ID: 28522244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thromboembolism.
    Fitzmaurice D; Hobbs FD; McManus R
    Clin Evid; 2002 Jun; (7):199-213. PubMed ID: 12230644
    [No Abstract]   [Full Text] [Related]  

  • 38. Low daily aspirin doses reduce risk of blood clots as effectively as higher doses.
    Rollins G
    Rep Med Guidel Outcomes Res; 2001 Feb; 12(4):5-7. PubMed ID: 11767795
    [No Abstract]   [Full Text] [Related]  

  • 39. Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Harrington RA; Becker RC; Ezekowitz M; Meade TW; O'Connor CM; Vorchheimer DA; Guyatt GH
    Chest; 2004 Sep; 126(3 Suppl):513S-548S. PubMed ID: 15383483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. International normalized ratio and anticoagulation.
    Theerman MR
    Arch Intern Med; 2003 May; 163(10):1242-3; author reply 1244. PubMed ID: 12767971
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.